Department of Pathology, Yale School of Medicine, New Haven, CT, USA.
Pediatr Dev Pathol. 2023 Jul-Aug;26(4):394-403. doi: 10.1177/10935266231175426. Epub 2023 Jun 19.
Hepatocellular adenoma (HCA) in the pediatric population is very rare and there are only limited studies, especially with molecular characterization of the tumors. Main HCA subtypes recognized in the current WHO classification include -inactivated HCA (H-HCA), inflammatory HCA (IHCA), β-catenin-activated HCA (b-HCA), and β-catenin-activated IHCA (b-IHCA) and sonic hedgehog HCA (shHCA) is reported as an emerging subtype.
Clinical history, pathological information, and molecular studies for a series of 2 cases of pediatric HCA were reviewed.
Case 1 was a b-HCA characterized by somatic S45 mutation in a 11-year-old male with Abernethy malformation. Case 2 was a H-HCA characterized by germline variant (c.526+1G>A) in a 15-year-old male associated with maturity-onset diabetes of the young type 3 (MODY3).
Our findings highlight the rarity of these 2 cases associated with adenomatosis, and the contribution of molecular/genetic analysis for proper sub-typing, prognosis and family surveillance.
儿童肝细胞腺瘤(HCA)非常罕见,目前仅有有限的研究,特别是对肿瘤的分子特征研究。目前世界卫生组织分类中主要的 HCA 亚型包括失活型 HCA(H-HCA)、炎症型 HCA(IHCA)、β-连环蛋白激活型 HCA(b-HCA)、β-连环蛋白激活型 IHCA(b-IHCA)和 sonic hedgehog HCA(shHCA),后者被报道为一种新兴亚型。
对 2 例儿科 HCA 患者的临床病史、病理信息和分子研究进行了回顾。
病例 1 是一名 11 岁男性,患有 Abernethy 畸形,表现为体细胞 S45 突变的 b-HCA。病例 2 是一名 15 岁男性,表现为 H-HCA,与青少年发病的成年型糖尿病 3 型(MODY3)相关,携带种系变异(c.526+1G>A)。
我们的发现强调了这 2 例与腺瘤病相关的罕见性,以及分子/遗传分析对正确分型、预后和家族监测的贡献。